BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27193872)

  • 1. Knockdown of COUP-TFII inhibits cell proliferation and induces apoptosis through upregulating BRCA1 in renal cell carcinoma cells.
    Zheng J; Qin W; Jiao D; Ren J; Wei M; Shi S; Xi W; Wang H; Yang AG; Huan Y; Wen W
    Int J Cancer; 2016 Oct; 139(7):1574-85. PubMed ID: 27193872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orphan nuclear receptor COUP-TFII is an oncogenic gene in renal cell carcinoma.
    Fang X; Liu CX; Zeng XR; Huang XM; Chen WL; Wang Y; Ai F
    Clin Transl Oncol; 2020 May; 22(5):772-781. PubMed ID: 31368079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COUP-TFII Knock-down Promotes Proliferation and Invasion in Colorectal Cancer Cells
    Yun SH; Han SH; Park JI
    Anticancer Res; 2020 Jan; 40(1):177-190. PubMed ID: 31892566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COUP-TFII in pancreatic adenocarcinoma: clinical implication for patient survival and tumor progression.
    Polvani S; Tarocchi M; Tempesti S; Mello T; Ceni E; Buccoliero F; D'Amico M; Boddi V; Farsi M; Nesi S; Nesi G; Milani S; Galli A
    Int J Cancer; 2014 Apr; 134(7):1648-58. PubMed ID: 24122412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNAi-mediated knockdown of vascular endothelial growth factor inhibits vascularization and tumor growth in renal cell carcinoma.
    Gu M; Zhang K; Yao HJ; Zhou J; Peng YB; Xu MX; Wang Z
    Int J Mol Med; 2015 Oct; 36(4):1063-72. PubMed ID: 26310563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM59 is a key regulator of growth and migration inrenal cell carcinoma.
    Hu SH; Zhao MJ; Wang WX; Xu CW; Wang GD
    Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):68-74. PubMed ID: 28719348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COUP-TFII promotes metastasis and epithelial-to-mesenchymal transition through upregulating Snail in human intrahepatic cholangiocarcinoma.
    Lang Q; Xiao P; Zhao M; Liang D; Meng Q; Pei T
    Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1247-1256. PubMed ID: 33166992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells.
    Ceni E; Mello T; Polvani S; Vasseur-Cognet M; Tarocchi M; Tempesti S; Cavalieri D; Beltrame L; Marroncini G; Pinzani M; Milani S; Galli A
    J Hepatol; 2017 Apr; 66(4):754-764. PubMed ID: 27866920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased chicken ovalbumin upstream promoter transcription factor II expression in tamoxifen-resistant breast cancer cells.
    Riggs KA; Wickramasinghe NS; Cochrum RK; Watts MB; Klinge CM
    Cancer Res; 2006 Oct; 66(20):10188-98. PubMed ID: 17047084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of ALPK2 blocks development and progression of renal cell carcinoma.
    Jiang J; Han P; Qian J; Zhang S; Wang S; Cao Q; Shao P
    Exp Cell Res; 2020 Jul; 392(2):112029. PubMed ID: 32330508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of RNA interference mediated VEGF gene silencing on biological behavior of renal cell carcinoma and transplanted renal tumor in nude mice.
    Wang Q; Wang S; Sun SQ; Cheng ZH; Zhang Y; Chen G; Gu M; Yao HJ; Wang Z; Zhou J; Peng YB; Xu MX; Zhang K; Sun XW
    Cancer Biomark; 2016; 16(1):1-9. PubMed ID: 26484606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COUP-TFII Overexpression Inhibits Cell Proliferation and Invasion
    Yun SH; Park JI
    Anticancer Res; 2020 Feb; 40(2):767-777. PubMed ID: 32014919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].
    Li CY; Yao AM; Chang XN; Guo YH; Xu R
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COUP-TFI and -TFII nuclear receptors are expressed in amacrine cells and play roles in regulating the differentiation of retinal progenitor cells.
    Inoue M; Iida A; Satoh S; Kodama T; Watanabe S
    Exp Eye Res; 2010 Jan; 90(1):49-56. PubMed ID: 19766631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The COUP-TFII variant lacking a DNA-binding domain inhibits the activation of the Cyp7a1 promoter through physical interaction with COUP-TFII.
    Yamazaki T; Suehiro J; Miyazaki H; Minami T; Kodama T; Miyazono K; Watabe T
    Biochem J; 2013 Jun; 452(2):345-57. PubMed ID: 23458092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UHRF1 promotes renal cell carcinoma progression through epigenetic regulation of TXNIP.
    Jiao D; Huan Y; Zheng J; Wei M; Zheng G; Han D; Wu J; Xi W; Wei F; Yang AG; Qin W; Wang H; Wen W
    Oncogene; 2019 Jul; 38(28):5686-5699. PubMed ID: 31043707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
    Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
    Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
    Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
    J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The INSL3 gene is a direct target for the orphan nuclear receptor, COUP-TFII, in Leydig cells.
    Mendoza-Villarroel RE; Di-Luoffo M; Camiré E; Giner XC; Brousseau C; Tremblay JJ
    J Mol Endocrinol; 2014 Aug; 53(1):43-55. PubMed ID: 24780841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of nucleolin as a COUP-TFII coactivator of retinoic acid receptor β transcription in breast cancer cells.
    Litchfield LM; Riggs KA; Hockenberry AM; Oliver LD; Barnhart KG; Cai J; Pierce WM; Ivanova MM; Bates PJ; Appana SN; Datta S; Kulesza P; McBryan J; Young LS; Klinge CM
    PLoS One; 2012; 7(5):e38278. PubMed ID: 22693611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.